IGMC Shimla extends Sahara Yojna benefits to 20 EWS patients

Published On 2019-07-22 03:59 GMT   |   Update On 2019-07-22 03:59 GMT

Shimla: Indra Gandhi Medical College Hospital Shimla, the premier Tertiary health institutions extended the benefit of Sahra Yojna to 20 economically weaker Section patients. Senior Medical Superintendent of Hospital Dr Janak Raj told UNI that IGMC is first institution to implement Sahara Yojna in the state which was notified by the Governor Acharay Dev Vrat on July 15, 2019.


The scheme launched at IGMC is providing finical assistance of Rs Two thousand per month to the patients belonging to the Economically Weaker Section (EWS) of the society and suffering from specified diseases or ailments. 


Also read:- IGMC Shimla registers record number of patient


All patients belonging to EWS of society baring Government and pensioners are covered under this scheme suffering with eight types of diseases including Parkinsonism, cancer, paralysis, permanent disability, muscular dystrophy, Hemophilia, Thalassemia and renal failure.


Around 6000 patients were identified to the various diseases with budgetary support 14.40 crore from the state government. In-addition to budgetary allocation Rs 14.40 lakh were allotted Administrative and other expenses.


Dr Janak said that about 13 patients suffering from Parkinson's, six patients with paralysis and One with Muscular dystrophy were benefited with this scheme as the first instalment was transferred to their bank account after implementing this scheme in IGMC.


Also read :- NGT gives nod to Rs 45 Cr Territory cancer care centre at IGMC


The government proposed to give an incentive of Rs 200 per beneficiary to Asha workers who facilitate identification of beneficiaries and completion of procedural formalities . While announcing first budget speech in State assembly Jai Ram Thakur launched this scheme in 2018-19 budget which was notified recently.


 
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News